Welcome to Monique Schiersing and Roel Bulthuis as new BoD members

NMD Pharma is proud to announce that Monique Schiersing will be joining the BoD of NMD Pharma representing Roche Venture Fond and that Roel Bulthuis has joined the NMD Pharma BoD representing Inkef Capital.

200527_New BoD members.jpg
Previous
Previous

NMD Pharma begins first clinical trial

Next
Next

Prominent Canadian researcher in Denmark: Why I left a top job in California